355 related articles for article (PubMed ID: 2468978)
1. A randomized clinical trial of 10% pentastarch (low molecular weight hydroxyethyl starch) versus 5% albumin for plasma volume expansion after cardiac operations.
London MJ; Ho JS; Triedman JK; Verrier ED; Levin J; Merrick SH; Hanley FL; Browner WS; Mangano DT
J Thorac Cardiovasc Surg; 1989 May; 97(5):785-97. PubMed ID: 2468978
[TBL] [Abstract][Full Text] [Related]
2. The safety and efficacy of ten percent pentastarch as a cardiopulmonary bypass priming solution. A randomized clinical trial.
London MJ; Franks M; Verrier ED; Merrick SH; Levin J; Mangano DT
J Thorac Cardiovasc Surg; 1992 Aug; 104(2):284-96. PubMed ID: 1379660
[TBL] [Abstract][Full Text] [Related]
3. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
[TBL] [Abstract][Full Text] [Related]
4. A prospective randomized study of hydroxyethyl starch, albumin, and lactated Ringer's solution as priming fluid for cardiopulmonary bypass.
Sade RM; Stroud MR; Crawford FA; Kratz JM; Dearing JP; Bartles DM
J Thorac Cardiovasc Surg; 1985 May; 89(5):713-22. PubMed ID: 2581099
[TBL] [Abstract][Full Text] [Related]
5. Effects of colloid or crystalloid administration on pulmonary extravascular water in the postoperative period after coronary artery bypass grafting.
Gallagher JD; Moore RA; Kerns D; Jose AB; Botros SB; Flicker S; Naidech H; Clark DL
Anesth Analg; 1985 Aug; 64(8):753-8. PubMed ID: 2409845
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of the intraoperative effectiveness of 5% human albumin or 10% hydroxyethyl starch (HAES-steril) on hemodynamics and oxygen transport in 40 patients].
Hankeln K; Senker R; Beez M
Infusionstherapie; 1990 Jun; 17(3):135-40. PubMed ID: 1697283
[TBL] [Abstract][Full Text] [Related]
7. The safety of modern hydroxyethyl starch in living donor liver transplantation: a comparison with human albumin.
Mukhtar A; Aboulfetouh F; Obayah G; Salah M; Emam M; Khater Y; Akram R; Hoballah A; Bahaa M; Elmeteini M; Hamza A
Anesth Analg; 2009 Sep; 109(3):924-30. PubMed ID: 19690268
[TBL] [Abstract][Full Text] [Related]
8. Limitations of blood conservation.
Weisel RD; Charlesworth DC; Mickleborough LL; Fremes SE; Ivanov J; Mickle DA; Teasdale SJ; Glynn MF; Scully HE; Goldman BS
J Thorac Cardiovasc Surg; 1984 Jul; 88(1):26-38. PubMed ID: 6376959
[TBL] [Abstract][Full Text] [Related]
9. Hemodynamic effects of 6% and 10% hydroxyethyl starch solutions versus 4% albumin solution in septic patients.
Friedman G; Jankowski S; Shahla M; Gomez J; Vincent JL
J Clin Anesth; 2008 Nov; 20(7):528-33. PubMed ID: 19019650
[TBL] [Abstract][Full Text] [Related]
10. Effects of intravascular volume therapy using hydroxyethyl starch (130/0.4) on post-operative bleeding and transfusion requirements in children undergoing cardiac surgery: a randomized clinical trial.
Chong Sung K; Kum Suk P; Mi Ja Y; Kyoung Ok K
Acta Anaesthesiol Scand; 2006 Jan; 50(1):108-11. PubMed ID: 16451158
[TBL] [Abstract][Full Text] [Related]
11. [A comparative study of the effectiveness of 5% human albumin and 10% hydroxyethyl starch (HAES-steril) for correcting hemodynamics and O2 transport in surgical interventions].
Hankeln K; Senker R; Beez M; Gol'dina OA
Anesteziol Reanimatol; 1997; (1):23-6. PubMed ID: 9173811
[TBL] [Abstract][Full Text] [Related]
12. Colloid preload versus coload for spinal anesthesia for cesarean delivery: the effects on maternal cardiac output.
Teoh WH; Sia AT
Anesth Analg; 2009 May; 108(5):1592-8. PubMed ID: 19372341
[TBL] [Abstract][Full Text] [Related]
13. [Changes in blood coagulation in treatment with hydroxyethyl starch].
Sefrin P; Rauch S; Zieglmeyer C
Anaesthesiol Reanim; 1998; 23(6):149-56. PubMed ID: 10036794
[TBL] [Abstract][Full Text] [Related]
14. Rapidly degradable hydroxyethyl starch solutions impair blood coagulation after cardiac surgery: a prospective randomized trial.
Schramko AA; Suojaranta-Ylinen RT; Kuitunen AH; Kukkonen SI; Niemi TT
Anesth Analg; 2009 Jan; 108(1):30-6. PubMed ID: 19095827
[TBL] [Abstract][Full Text] [Related]
15. Safety of HES 130/0.4 (Voluven(R)) in patients with preoperative renal dysfunction undergoing abdominal aortic surgery: a prospective, randomized, controlled, parallel-group multicentre trial.
Godet G; Lehot JJ; Janvier G; Steib A; De Castro V; Coriat P
Eur J Anaesthesiol; 2008 Dec; 25(12):986-94. PubMed ID: 18492315
[TBL] [Abstract][Full Text] [Related]
16. Volume therapy with a new hydroxyethyl starch solution in cardiac surgical patients before cardiopulmonary bypass.
Boldt J; Lehmann A; Römpert R; Haisch G; Isgro F
J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):264-8. PubMed ID: 10890478
[TBL] [Abstract][Full Text] [Related]
17. [The maximum safe dosage of the low molecular weight hydroxyethyl starch, HESPANDAR (HES), estimated from HES induced changes in coagulation parameters and clinical bleeding].
Saito Y; Uchida K; Yamamoto H; Ichiishi N; Matsushita F
Masui; 1999 Mar; 48(3):238-43. PubMed ID: 10214006
[TBL] [Abstract][Full Text] [Related]
18. Perioperative volume replacement in children undergoing cardiac surgery: albumin versus hydroxyethyl starch 130/0.4.
Hanart C; Khalife M; De Villé A; Otte F; De Hert S; Van der Linden P
Crit Care Med; 2009 Feb; 37(2):696-701. PubMed ID: 19114887
[TBL] [Abstract][Full Text] [Related]
19. Crystalloid versus colloid fluid therapy after cardiac surgery.
Ley SJ; Miller K; Skov P; Preisig P
Heart Lung; 1990 Jan; 19(1):31-40. PubMed ID: 1688835
[TBL] [Abstract][Full Text] [Related]
20. [Effect of hydroxyethyl starch HES 450/0.7 and 5% human albumin on the colloid osmotic pressure and hemodynamic parameters in hypovolemic patients after major abdominal procedures].
Gahr R; Bock PR
Infusionsther Klin Ernahr; 1981 Jun; 8(3):147-52. PubMed ID: 6167516
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
